अगला

स्वत: प्ले

Camrelizumab + Apatinib for Highrisk Chemorefractory or Relapsed Gestational Trophoblastic Neoplasia

1 विचारों • 06/30/23
शेयर करना
एम्बेड
administrator
administrator
ग्राहकों
0

Warm Welcome to the latest OncoShorts podcast, brought to you by MedSynapse. OncoShorts covers a wide range of clinical and scientific medical content, that offers enriching insights into the World of Oncology.

In today’s podcast episode, we will discuss details of a randomized phase 2 trial, titled, Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia, featured in the November 2021 Issue of The Lancet Oncology.

और दिखाओ
0 टिप्पणियाँ sort इसके अनुसार क्रमबद्ध करें
फेसबुक टिप्पणियाँ

अगला

स्वत: प्ले